AbsEn.i
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration SRAS - Analysis (2020)

Index « AbsEn.i » - entrée « response »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
responding < response < responses  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 85.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000013 (2020) Adrien Breiman [France] ; Nathalie Ruvën-Clouet [France] ; Jacques Le Pendu [France]Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2
000019 (2020) Y J Liu [République populaire de Chine] ; Y L Yang [République populaire de Chine] ; Y. Xu [République populaire de Chine][What we learned from SARS may provide important insights into understanding and management of coronavirus disease 2019].
000028 (2020) [Response plan in the neonatal intensive care unit during epidemic of SARS-CoV-2 infection (2nd Edition)].
000030 (2020) Yeyan He [République populaire de Chine] ; Chanying Zheng [République populaire de Chine][Replication and transmission mechanisms of highly pathogenic human coronaviruses].
000032 (2020) Ming Niu [République populaire de Chine] ; Rui-Lin Wang [République populaire de Chine] ; Zhong-Xia Wang [République populaire de Chine] ; Ping Zhang [République populaire de Chine] ; Zhao-Fang Bai [République populaire de Chine] ; Jing Jing [République populaire de Chine] ; Yu-Ming Guo [République populaire de Chine] ; Xu Zhao [République populaire de Chine] ; Xiao-Yan Zhan [République populaire de Chine] ; Zi-Teng Zhang [République populaire de Chine] ; Xue-Ai Song [République populaire de Chine] ; En-Qiang Qin [République populaire de Chine] ; Jia-Bo Wang [République populaire de Chine] ; Xiao-He Xiao [République populaire de Chine][Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking].
000034 (2020) Y. Shi [République populaire de Chine] ; N. Wang [République populaire de Chine] ; Q M Zou [République populaire de Chine][Progress and challenge of vaccine development against 2019 novel coronavirus (2019-nCoV)].
000040 (2020) X. Wang [République populaire de Chine] ; Y Q Ding [République populaire de Chine][From SARS to COVID-19: pathogens, receptor, pathogenesis and principles of the treatment].
000045 (2020) Zheng Chen [République populaire de Chine] ; Li-Zhong Du ; Jun-Fen Fu ; Qiang Shu ; Zhi-Min Chen ; Li-Ping Shi ; Wei Wang ; Shuo-Hui Chen ; Xiao-Lu Ma ; Sheng Ye ; Wei Sun ; Ming-Yan Chen ; Hai-Hong Zhu ; Guo-Lan Huang ; Fei-Xiang Luo[Emergency plan for inter-hospital transfer of newborns with SARS-CoV-2 infection].
000059 (2020) Catrin Sohrabi [Royaume-Uni] ; Zaid Alsafi [Royaume-Uni] ; Niamh O'Neill [Royaume-Uni] ; Mehdi Khan [Royaume-Uni] ; Ahmed Kerwan [Royaume-Uni] ; Ahmed Al-Jabir [Royaume-Uni] ; Christos Iosifidis [Royaume-Uni] ; Riaz Agha [Royaume-Uni]World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)
000062 (2020) Binqing Fu [République populaire de Chine] ; Xiaoling Xu [République populaire de Chine] ; Haiming Wei [République populaire de Chine]Why tocilizumab could be an effective treatment for severe COVID-19?
000067 (2020) Mary A. Lake [Royaume-Uni]What we know so far: COVID-19 current clinical knowledge and research.
000084 (2020) Use of Rapid Online Surveys to Assess People's Perceptions During Infectious Disease Outbreaks: A Cross-sectional Survey on COVID-19
000087 (2020) Daniel B. JerniganUpdate: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020.
000094 (2020) Yu-Tao Xiang [République populaire de Chine] ; Yu Jin [République populaire de Chine] ; Yu Wang [République populaire de Chine] ; Qinge Zhang [République populaire de Chine] ; Ling Zhang [République populaire de Chine] ; Teris Cheung [République populaire de Chine]Tribute to health workers in China: A group of respectable population during the outbreak of the COVID-19.
000099 (2020) Yong Xiong [République populaire de Chine] ; Yuan Liu [République populaire de Chine] ; Liu Cao [République populaire de Chine] ; Dehe Wang [République populaire de Chine] ; Ming Guo [République populaire de Chine] ; Ao Jiang [République populaire de Chine] ; Dong Guo [République populaire de Chine] ; Wenjia Hu [République populaire de Chine] ; Jiayi Yang [République populaire de Chine] ; Zhidong Tang [République populaire de Chine] ; Honglong Wu [République populaire de Chine] ; Yongquan Lin [République populaire de Chine] ; Meiyuan Zhang [République populaire de Chine] ; Qi Zhang [République populaire de Chine] ; Mang Shi [République populaire de Chine] ; Yingle Liu [République populaire de Chine] ; Yu Zhou [République populaire de Chine] ; Ke Lan [République populaire de Chine] ; Yu Chen [République populaire de Chine]Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.
000111 (2020) Rohit Shetty [Inde] ; Arkasubhra Ghosh [Inde] ; Santosh G. Honavar [Inde] ; Pooja Khamar [Inde] ; Swaminathan Sethu [Inde]Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future.
000122 (2020) Qing Ye [République populaire de Chine] ; Bili Wang [République populaire de Chine] ; Jianhua Mao [République populaire de Chine]The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.
000151 (2020) Peter P. Liu [Canada] ; Alice Blet [France] ; David Smyth [Canada] ; Hongliang Li [République populaire de Chine]The Science Underlying COVID-19: Implications for the Cardiovascular System.
000167 (2020) Leon Caly [Australie] ; Julian D. Druce [Australie] ; Mike G. Catton [Australie] ; David A. Jans [Australie] ; Kylie M. Wagstaff [Australie]The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.
000179 (2020) Pranab Chatterjee [Inde] ; Nazia Nagi [Inde] ; Anup Agarwal [Inde] ; Bhabatosh Das [Inde] ; Sayantan Banerjee [Inde] ; Swarup Sarkar [Inde] ; Nivedita Gupta [Inde] ; Raman R. Gangakhedkar [Inde]The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current evidence.
000195 (2020) Denis C. Bauer [Australie] ; Aidan P. Tay [Australie] ; Laurence O W. Wilson [Australie] ; Daniel Reti [Australie] ; Cameron Hosking [Australie] ; Alexander J. Mcauley [Australie] ; Elizabeth Pharo [Australie] ; Shawn Todd [Australie] ; Vicky Stevens [Australie] ; Matthew J. Neave [Australie] ; Mary Tachedjian [Australie] ; Trevor W. Drew [Australie] ; S S Vasan [Australie]Supporting pandemic response using genomics and bioinformatics: a case study on the emergent SARS-CoV-2 outbreak.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "response" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "response" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    response
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021